Feature Card Laszlo Prokai July22

Treating hot flashes without the side effects

Experimental drug could treat hot flashes, other symptoms of menopause without harmful side effects Researchers have discovered an experimental medication that treats hot flashes and other menopausal symptoms without the life-threatening risks of hormone replacement therapy, according to a team led by a UNT Health Science Center scientist. In a study appearing in the July…
Sid Obryant Sheryl Sewell Leigh Johnson FC

Children continue mother’s legacy with Alzheimer’s research gift

More than 40 years ago, Jareen Schmidt founded the J.E.S. Edwards Foundation to support issues dear to her heart, such as health and wellness in Fort Worth. So when Alzheimer’s disease required her to transfer Foundation leadership duties to her children, they knew how to continue her legacy. The foundation made a gift to advance…
Hongli Wu FC

Stopping a disabling eye disease

What if you couldn’t see well enough to drive, read or cook, or even recognize the face of your child or best friend? That happens to many people who have age-related macular degeneration (AMD). About 15 million Americans have the disease, according to the American Society of Retina Specialists. AMD is the No. 1 reason…
Shaohua Yang stroke research FC

A wider window for treating stroke

When someone has a stroke, there’s a very narrow window – three hours or less –when the drug tPA can be used to dissolve blood clots and restore blood flow. But few people benefit from this treatment because they don’t get care fast enough, said Shaohua Yang, PhD, MD, Professor of Pharmacology and Neuroscience. By…
Rebecca Cunningham Research FC

Is there a testosterone link to Parkinson’s?

Parkinson’s disease affects more men than women, but no one knows why. Understanding what puts men at a two- to-three times greater risk of this progressive neurological disorder, best known for causing tremors, could shed light on this condition and one day lead to medications to treat it, said Rebecca Cunningham, PhD, Assistant Professor of…
Dr Bob Luedtke FC WEB

Research seeks way to block euphoria associated with cocaine use

Research underway at UNT Health Science Center could lead to a medication to treat cocaine addiction. Cocaine is a highly addictive drug, and about 80 percent of cocaine abusers relapse six months after leaving a rehabilitation facility.  A medication that could block the effects of cocaine might be useful as part of a rehabilitation program.…
SID BLOOD RESEARCH FC1

Guidelines bring Alzheimer’s blood test one step closer

A simple blood test to detect early Alzheimer's disease is a step closer to being used to screen older adults. Detailed standardized guidelines that are needed before a blood test could be used in practice have been published in Alzheimer's & Dementia. The guidelines establish protocols and reflect the continued efforts of an international working…
RUTLEDGE FOUNDATION FC1

Grant to aid cancer treatment research

An experimental vaccine gave Carley Rutledge the chance to live a full life after Ewing's sarcoma nearly took it away when she was 15. Now 20, she's a college student studying conservation biology and chemistry. The same positive outlook could one day be shared by other young adult cancer survivors thanks to research being conducted…

Forster awarded Denham Harman Award for aging research

For more than three decades, Michael Forster, PhD, has studied ways to slow the aging process and help people live longer, healthier lives. In May, the American Aging Association will present Dr. Forster, Chair of Pharmacology & Neuroscience, with the Denham Harman Research Award. Named after the association's co-founder, the award honors those who have…

RAD speaker says national network to help recruitment for clinical trials

Clinical trials can pave the way for new life-saving treatments, but they often fail because investigators are unable to recruit patients. A new national network of institutions could make it easier to recruit patients and ultimately move the field of medicine forward, said Dr. Robert Toto, the keynote speaker for the 23rd annual Research Appreciation…